Aside from the implication of Cox-2, in breast cancer cells, receptor activator of NF-κB ligand (RANKL) was revealed to downregulate the E-cadherin expression by activating the NF-κB pathway and enhancing Snail and Twist expression [50]. Here, CDH1 is linked to breast carcinoma.